in this issue
Regions :: Southeast Asia :: Singapore
Roche Agrees to Buy Lonza's Singapore Manufacturing Facility
1:49 AM MDT | August 31, 2009 | Natasha Alperowicz
Lonza has announced that Genentech Singapore, a wholly-owned member of the Roche Group, has elected to exercise an option to purchase from Lonza its cell culture biologic manufacturing facility in Singapore for $290 million plus additional milestone payments of $70 million. The facility, which is mechanically completed, will be merged with Genentech Singapore's existing biologic manufacturing facility. As part of the integration between Roche's and Genentech's combined technical operations, the biotechnology production facilities in Singapore currently operating...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee